Aequs listing expectations: Analysts advised investors to book partial profits on listing gains and holding the rest for long term.
The capital markets regulator has issued observations on the draft document of Molbio Diagnostics on December 1, followed by Leap India, and Eldorado Agritech on December 5
The home-solutions brand plans faster furniture-led growth and a major Tier-2 retail rollout as its Rs 1,289-crore IPO opens for public subscription.
The Bengaluru-based company has held preliminary discussions with bankers about a potential listing
Wakefit IPO share allotment is expected by December 11, while the shares are proposed to be listed on December 15.
Corona Remedies IPO: The price band for the IPO has been set at Rs 1,008-1,062 per share.
Deven Choksey, has come out with its report on Wakefit Innovations Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 08, 2025.
Helloji Holidays share price: The Rs 11-crore IPO saw strong investor interest during its three days of public bidding, being subscribed more than 27 times from December 2-4.
Shares of Meesho, Aequs and Vidya Wires are showing a firm trend in the grey market, with premiums of about 35 percent.
Both companies will finalise their IPO share allotment by December 9, while their shares will be available for trading on the BSE SME effective December 11.
Nephrocare Health Services IPO | The company approached capital markets to raise Rs 871 crore via initial public offering (IPO) comprising fresh issuance of shares worth Rs 353.4 crore.
The proceeds surpassed last year’s high of Rs 1.73 lakh crore, according to data compiled by Bloomberg
As the AMC heads into its IPO, Shah says low fees strengthen — not strain — the business, backed by counter-cyclical products and a rapidly maturing investor base.
India’s second-largest fund house readies three SIF products as it debuts on the bourses; Shah says the new category will complement—not dilute—its MF franchise.
Corona Remedies IPO GMP: Corona Remedies launched its IPO today to raise more than Rs 655 crore entirely through an offer for sale (OFS) of shares with no fresh issue component.
Wakefit IPO GMP: The shares of the company may become attractive to investors with a long-term thesis on consumption growth instead of a short-term listing pop play, an analyst said.
Aequs IPO shares will be listed on both NSE and BSE platforms on December 10, following a whopping 101.63 times subscription in the primary market.
Vidya Wires IPO allotment today: Ahead of listing, the unlisted shares of the company were trading with nearly 8% GMP over the IPO price.
Astron Multigrain share price: Ahead of listing, the unlisted shares of the company were trading flat at the IPO price of Rs 63 per share, with zero GMP, according to data on IPO Watch.
Ravelcare share price: The listing premium is slightly higher than the grey market estimates.
The Rs 28.12 crore issue had a price band of Rs 80-85 per share. The company's market capitalization post listing of shares stood at Rs 125.72-crore.
IPO Allotment Status: Applicants can check their allotment status online on the official websites of BSE and NSE, as well as the official website of the registrar of the respective IPO.
Valuation looks expensive though the company is poised for growth
Meesho IPO shares will be listed on both NSE and BSE platforms on December 10, following a strong subscription of 79 times to its Rs 5,421-crore issue.
Bengaluru-based home & furnishings company Wakefit Innovations, and pharmaceutical firm Corona Remedies will be the first amongst them in the mainboard segment, opening IPOs on December 8 with price band of Rs 185-195 per share and Rs 1,008-1,062 per share, respectively.
